Clinical Trial Update: Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating non-invasive vagal nerve stimulation for opioid use disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder
• Opioid Withdrawal

Drugs mentioned

• Non-invasive vagal nerve stimulation

Snippet

Sponsor: Emory University | Conditions: Withdrawal Symptoms, Opioid Use Disorder | Phase 3 | Status: RECRUITING